Starg Wuhan Pharmaceutical Tech Co Ltd. is an innovative drug research and development company based in China and facing the world. It was founded by a number of senior figures in the biomedical industry. The company focuses on the field of tumor immunity and synthetic lethal therapies for tumors, while also arranging targets for major unmet clinical needs such as the central nervous system and autoimmune diseases, focusing on innovations with "First in China" and "Best in Class" development potential. Drug research and development. At present, many projects have made breakthrough progress.
The company's core team has an average of more than 10 years of innovative drug research and development experience in the fields of oncology, central nervous system, and autoimmune diseases. They have keen insight into the establishment of high-value and high-potential target projects, and are based on AIDD/CADD combined with pharmacochemistry. With expert experience, we can quickly design and optimize high-quality clinical candidate compounds, and at the same time, we can efficiently and quickly complete IND and conduct clinical stage development.
Controllable Risk
Controllable Cost
Controllable Progress
Agility
Rich Experience
Tacit Cooperation
Research General Manager
Department of Biology, Tsinghua University (Bachelor, Master, Ph.D.). MBA from China Europe International Business School, 4 years of experience in scientific research management and business management consulting. Represented China at the 2015 World Youth Agriculture Summit and submitted a synthetic biology plan.
Director of Pharmacy and Chemistry
Master's degree in Medicinal Chemistry.15 years of experience in pharmaceutical research and development, with successful development experience in multiple projects, and has developed multiple "Best in class" products recognized by customers.Good at: quickly creating new IP and developing products with excellent properties.
Director of Pharmacy and Chemistry
Master of Medicinal Chemistry, with 16 years of experience in innovative drug R&D management. He has completed IND applications for multiple projects in the fields of oncology, central nervous system and kidney disease, and many projects have entered clinical phase 2 and achieved good results. He is good at molecular design and project differentiation. development.
Patent director
Tianjin University Pharmaceutical Engineering major(Bachelor’s and Master’s), 5 years of first-line small-molecule drug research and development experience, 2 years of pharmaceutical patent examination experience, 2 years of IPR experience in large pharmaceutical companies, a major participant in the 2022 top 10 review cases; Good at: application writing, retrieval, FTO analysis.
CHO
Master of Management, serial entrepreneur, one of the top ten young entrepreneurial figures in Hubei Province, and a member of the National College Graduate Employment and Entrepreneurship Steering Committee.Good at: Integrating human resources among scientists in the biomedical industry.
©Copyright2021 Starg (Wuhan) Pharmaceutical Tech Co Ltd. EICPB No. 2023031485
